Sign in

CIK 0001125345

  • Non-accelerated filer
  • Smaller reporting company

MACROGENICS INC

Sign in to watch
Ticker
MGNX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 301-251-5172
Business address
9704 MEDICAL CENTER DRIVE, Rockville, MD, 20850
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-05-17 Fust Matthew K Director Grant or award · Stock Option (right to buy) +10,000 10,000
2018-03-12 Risser Eric Blasius Sr VP & Chief Business Officer Exercise or conversion +1,000 $0.94 $940 10,100
2018-03-12 Risser Eric Blasius Sr VP & Chief Business Officer Sale −1,000 $31.08 $31K 9,100
2018-03-12 Risser Eric Blasius Sr VP & Chief Business Officer Exercise or conversion · Employee stock option (right to buy) −1,000 20,497
2018-03-05 Karrels James SVP, CFO and Secretary Sale −5,000 $31.00 $155K 114,847
2018-03-05 Risser Eric Blasius Sr VP & Chief Business Officer Exercise or conversion · Employee stock option (right to buy) −4,000 21,497
2018-03-02 Karrels James SVP, CFO and Secretary Grant or award · Employee stock option (right to buy) +70,000 70,000
2018-03-02 Peters Jeffrey Stuart Acting General Counsel Grant or award · Employee stock option (right to buy) +50,000 50,000
2018-03-02 Bonvini Ezio Sr VP, Research & CSO Grant or award · Employee stock option (right to buy) +70,000 70,000
2018-03-02 Risser Eric Blasius Sr VP & Chief Business Officer Exercise or conversion +4,000 $0.94 $4K 13,100
2018-03-02 Risser Eric Blasius Sr VP & Chief Business Officer Sale −4,000 $30.00 $120K 9,100
2018-03-02 Risser Eric Blasius Sr VP & Chief Business Officer Grant or award · Employee stock option (right to buy) +70,000 70,000
2018-03-02 Wigginton Jon Marc Sr VP, Clinical Dev. & CMO Grant or award · Employee stock option (right to buy) +70,000 70,000
2018-03-02 Koenig Scott President and CEO Grant or award · Employee stock option (right to buy) +225,000 225,000
2018-03-02 Spitznagel Thomas Sr VP, BPD & Manufacturing Grant or award · Employee stock option (right to buy) +50,000 50,000
2018-03-02 Cilinski Lynn VP, Controller and Treasurer Grant or award · Employee stock option (right to buy) +28,000 28,000
2018-02-28 Risser Eric Blasius Sr VP & Chief Business Officer Exercise or conversion +1,000 $0.94 $940 10,100
2018-02-28 Risser Eric Blasius Sr VP & Chief Business Officer Sale −1,000 $25.01 $25K 9,100
2018-02-28 Risser Eric Blasius Sr VP & Chief Business Officer Exercise or conversion · Employee stock option (right to buy) −1,000 25,497
2018-02-28 Cilinski Lynn VP, Controller and Treasurer Exercise or conversion +7,989 $0.94 $8K 9,912

Page 32 of 35 · 684 trades